Frontiers in Anti-Cancer Drug Discovery

Volume: 1

Indexed in: Scopus, Book Citation Index, Science Edition (BKCI-S), Web of Science, BIOSIS Previews, Scopus, EMBASE, Chemical Abstracts, EBSCO, Ulrich's Periodicals.

“Frontiers in Anti-Cancer Drug Discovery” is an eBook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write ...
[view complete introduction]

US $
15

*(Excluding Mailing and Handling)



Recent Patents on Therapeutic Agents for Cancer

Pp. 623-740 (118)

Xun Li, Yalin Li and Wenfang Xu

Abstract

Cancer is one of the most dreaded diseases with a complex pathogenesis, which threats human life greatly. Multidisciplinary scientific investigations are making best efforts to combat this disease and put to the identification of novel anticancer agents. Patent anticancer agents registered in China are therefore increasing dramatically during the past ten years, which will be reviewed briefly in this article.

I. Platinum complexes

II. Anthracycline analogs (including doxorubicin derivatives)

III. Quinoline analogs

IV. Podophyllotoxins analogs

V. Taxane analogs

Keywords:

Anticancer, therapeutic agents, platinum complex, anthracycline, quinoline, podophyllotoxins, taxane, camptothecin, derivatives, analogs, pharmaceutical combinations, preparation, application

Affiliation:

Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Ji'nan 250012, Shandong Province, P.R. China